ALB and metabolic dysfunction-associated steatohepatitis: To test whether elimination of OxPCs through inducible expression of scFv-E06 during the transition from steatosis to NASH could halt the progression to fibrosis, we first fed age-matched Alb-cre mice an FPC diet for 6 weeks (Fig. 5A), which established hepatic steatosis without signs of fibrosis.